Interferon alfa down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice

Hepatology

Volumn 38, Issue 4, 2003, Pages 890-899

  Inagaki, Yutaka ^a   Nemoto, Tomoyuki ^b   Kushida, Miwa ^a   Sheng, Yin ^a   Higashi, Kiyoshi ^c   Ikeda, Kazuo ^d   Kawada, Norifumi ^d   Shirasaki, Fumiaki ^e   Takehara, Kazuhiko ^e   Sugiyama, Kota ^f   Fujii, Mitsukiyo ^g   Yamauchi, Hiroshi ^g   Nakao, Atsuhito ^h   De Crombrugghe, Benoit ⁱ   Watanabe, Tetsu ^a   Okazaki, Isao ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c SUMITOMO CHEMICAL CO LTD   (Japan)

^d OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e KANAZAWA UNIVERSITY   (Japan)

^f OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^g HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

^h JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; CARBON TETRACHLORIDE; COLLAGEN; RECOMBINANT GAMMA INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FIBROGENESIS; LIVER FIBROSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

EID: 0141643408     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50408     Document Type: Article

References (50)

1. Rojkind M, Ponce-Noyola P. The extracellular matrix of the liver. Collagen Rel Res 1982;2:151-175.
2. Kobayashi M, Tanaka E, Sodeyama T, Urushihara A, Matsumoto A, Kiyosawa K. The natural course of chronic hepatitis C: a comparison between patients with genotype 1 and 2 hepatitis C viruses. HEPATOLOGY 1996;23:695-699.
3. Yano M, Kumada H, Kage M, Ikeda K, Shimamatsu K, Inoue O, Hashimoto E, et al. The long-term pathological evolution of chronic hepatitis C. HEPATOLOGY 1996;23:1334-1340.
4. Hiramatsu N, Hayashi N, Kasahara A, Hagiwara H, Takehara T, Haruna Y, Naito M. Improvement of liver fibrosis in chronic hepatitis patients treated with natural interferon alpha. J Hepatol 1995;22:135-142.
5. Suou T, Hosho K, Kishimoto Y, Horie Y, Kawasaki H. Long-term decrease in serum N-terminal propeptide of type III procollagen in patients with chronic hepatitis C treated with interferon alfa. HEPATOLOGY 1995;22:426-431.
6. Manabe N, Chevallier M, Chossegros P, Causse X, Guerret S, Trepo C, Grimaudo JA. Interferon-α 2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: a quantitative histological evaluation. HEPATOLOGY 1993;18:1344-1349.
7. Duchatelle V, Marcellin P, Giostra E, Bregeaud L, Pouteau M, Boyer N, Auperin A. Changes in liver fibrosis at the end of alpha interferon therapy and 6 to 18 months later in patients with chronic hepatitis C: quantitative assessment by a morphometric method. J Hepatol 1998;29:20-28.
8. Sobesky R, Mathurin P, Charlotte F, Moussalli J, Olivi M, Vidaud M, Ratziu V, et al. Modeling the impact of interferon alpha treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. Gastroenterology 1999;116:378-386.
9. Tsushima H, Kawata S, Tamura S, Ito N, Shirai Y, Kiso S, Doi Y, et al. Reduced plasma transforming growth factor-β1 levels in patients with chronic hepatitis C after interfeton-α therapy: association with regression of hepatic fibrosis. J Hepatol 1999;30:1-7.
10. Ramirez F, Di Liberto M. Complex and diversified regulatory programs control the expression of vertebrate collagen gene. FASEB J 1990;4:1616-1623.
11. Inagaki Y, Truter S, Ramirez F. Transforming growth factor-β stimulates α2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site. J Biol Chem 1994;269:14828-14834.
12. Greenwel P, Inagaki Y, Hu W, Walsh M, Ramirez F. Sp1 is required for the early response of α2(I) collagen to transforming growth factor-β1. J Biol Chem 1997;272:19738-19745.
13. Zhang W, Oul J, Inagaki Y, Greenwel P, Ramirez F. Synergistic cooperation between Sp1 and Smad3/Smad4 mediates TGFβ1 stimulation of α2(I) collagen (COL1A2) transcription. J Biol Chem 2000;275:39237-39245.
14. Inagaki Y, Truter S, Greenwel P, Rojkind M, Unoura M, Kobayashi K, Ramirez F. Regulation of the α2(I) collagen gene transcription in fat-storing cells derived from a cirrhotic liver. HEPATOLOGY 1995;22:573-579.
15. Inagaki Y, Mamura M, Kanamaru Y, Greenwel P, Nemoto T, Takehara K, ten Dijke P, et al. Constitutive phosphorylation and nuclear localization of Smad3 are correlated with increased collagen gene transcription in activated hepatic stellate cells. J Cell Physiol 2001;187:117-123.
16. Bou-Gharios G, Garrett LA, Rossert J, Niederreither K, Eberspaecher H, Smith C, Black C, et al. A potent far-upstream enhancer in the mouse proα2(I) collagen gene regulates expression of reporter genes in transgenic mice. J Cell Biol 1996;134:1333-1344.
17. De Val S, Ponticos M, Antoniv TT, Wells DJ, Abraham D, Partridge T, Bou-Gharios G. Identification of the key regions within the mouse pro-α2(I) collagen gene far-upstream enhancer. J Biol Chem 2002;277:9286-9292.
18. Inagaki Y, Truter S, Bou-Ghatios G, Gartett L-A, de Crombrugghe B, Nemoto T, Greenwel P. Activation of proα2(I) collagen promoter during hepatic fibrogenesis in transgenic mice. Biochem Biophys Res Commun 1998;250:606-611.
19. Fukuda S, Fujii M, Koide K, Takimoto A, Yamamoto S, Aga M, Goto K, et al. Large scale production and purification of natural murine interferon-α /β. Kagaku To Kogyo (Osaka) 1992;66:404-406.
20. Sehgal PB, May LT, Landsberger FR. Primary structural repeats in human and murine γ-interferon. J Interferon Res 1986;6:39-42.
21. Watanabe T, Niioka M, Hozawa S, Kameyama K, Hayashi T, Arai M, Ishikawa A, et al. Gene expression of interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachloride. J Hepatol 2000;33:224-235.
22. Kristensen DB, Kawada N, Imamura K, Miyamoto Y, Tateno C, Seki S, Kuroki T, et al. Proteome analysis of rat hepatic stellate cells. HEPATOLOGY 2000;32:268-277.
23. Greenwel P, Rubin J, Schwartz M, Hertzberg EL, Rojkind M. Liver fat-storing cell clones obtained from a CCl4-cirrhotic rat are heterogeneous with regard to proliferation, expression of extracellular matrix components, interleukin-6, and connexin 43. Lab Invest 1993;69:210-217.
24. Inagaki Y, Nemoto T, Nakao A, ten Dijke P, Kobayashi K, Takehara K, Greenwel P. Interaction between GC box binding factors and Smad proteins modulates cell lineage-specific α2(I) collagen gene transcription. J Biol Chem 2001;276:16573-16579.
25. Inagaki Y, Truter S, Tanaka S, Di Liberto M, Ramirez F. Overlapping pathways mediate the opposing actions of tumor necrosis factor-α and transforming growth factor-β on α2(I) collagen gene transcription. J Biol Chem 1995;270:3353-3358.
26. Higashi K, Inagaki Y, Suzuki N, Mitsui S, Mauviel A, Kaneko H, Nakatsuka I. Y-box-binding protein YB-1 mediates transcriptional repression of human α2(I) collagen gene expression by interferon-γ. J Biol Chem 2003;278:5156-5162.
27. Uze G, Lutfalla G, Gresser I. Genetic transfer of a functional human interferon α receptor into mouse cells: cloning and expression of its CDNA. Cell 1990;60:225-234.
28. Domanski P, Witte M, Kellum M, Rubinstein M, Hackett R, Pitha P, Colamonici OR. Cloning and expression of a long form of the β subunit of the interferon αβ receptor that is required for signaling. J Biol Chem 1995;270:21606-21611.
29. Yan H, Krishnan K, Lim JTE, Contillo LG, Krolewski JJ. Molecular characterization of an alpha interferon receptor 1 subunit (IFNaR1) domain required for TYK2 binding and signal transduction. Mol Cell Biol 1996;16:2074-2082.
30. Novick D, Cohen B, Rubinstein M. The human interferon α/β receptor: characterization and molecular cloning. Cell 1994;77:391-400.
31. Elder GA, Liang Z, Li C, Lazzarini RA. Targeting of Sp1 to a non-Sp1 site in the human neurofilament (H) promoter via an intermediary DNA-binding protein. Nucleic Acids Res. 1992;20:6281-6285.
32. Nakao A, Imamura T, Souchenlnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, et al. TGF-β receptor-mediated signalling through Smad2, Smad3, and Smad4. EMBO J 1997;16:5353-5362.
33. Nishihara A, Hanai J, Imamura T, Miyazono K, Kawabata M. E1A inhibits transforming growth factor-β signaling through binding to Smad proteins. J Biol Chem 1999;274:28716-28723.
34. Boast S, Su M-W, Ramirez F, Sanchez M, Avvedimentro EV. Functional analysis of cis-acting DNA sequences controlling transcription of the human type I collagen gene. J Biol Chem 1990;265:13351-13356.
35. Ghosh AK, Yuan W, Mori Y, Varga J. Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-β involves functional cooperation with p300/CBP transcriptional coactivators. Oncogene 2000;19:3546-3555.
36. Ghosh AK, Yuan W, Mori Y, Chen SJ, Varga J. Antagonistic regulation of type I collagen gene expression by interferon-γ and transforming growth factor-β. Integration at the level of p300/CBP transcriptional coactivators. J Biol Chem 2001;276:11041-11048.
37. Fott J, Pilette C, Veal N, Oberti F, Gallois Y, Douay O, Rosenbaum J, et al. Effects of long-term administration of interferon α in two models of liver fibrosis in rats. J Hepatol 1998;29:263-270.
38. Czaja MJ, Weiner FR, Takahashi S, Giambrone M-A, van der Meide P, Schellekens H, Biempica L, et al. γ-interferon treatment inhibits collagen deposition in murine Schistosomiasis. HEPATOLOGY 1989;10:795-800.
39. Baroni GS, D'Ambrosio L, Curto P, Casini A, Mancini R, Jezequel AM, Benedetti A. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. HEPATOLOGY 1996;23:1189-1199.
40. Lortat-Jacob H, Baltzer F, Desmouliere A, Peyrol S, Grimaud JA. Lobular, but not periovular, inhibition of collagen deposition in the liver of S. mansoni-infected mice using interfeton-γ. J Hepatol 1997;26:894-903.
41. Sakaida I, Uchida K, Matsumura Y, Okita K. Interferon gamma treatment prevents collagen gene expression without affecting transforming growth factor-β1 expression in pig serum-induced rat liver fibrosis in vivo. J Hepatol 1998;28:471-479.
42. Takaoka A, Mitani Y, Suemori H, Sato M, Yokochi T, Noguchi S, Tanaka N, et al. Cross talk between interferon-γ and α/β signaling components in caveolar membrane domains. Science 2000;288:2357-2360.
43. Kähäri VM, Chen YQ, Su MW, Ramirez F, Uitto J. Tumor necrosis factor-α and interferon-γ suppress the activation of human type I collagen gene expression by transforming growth factor-β. J Clin Invest 1990;86:1489-1495.
44. Rockey DC, Maher JJ, Jarnagin WR, Gabbiani G, Friedman SL. Inhibition of rat hepatic lipocyte activation in culture by interferon-γ. HEPATOLOGY 1992;16:776-784.
45. Mallat A, Preaux A-M, Blazejewski S, Rosenbaum J, Dhumeaux D, Mavier P. Interferon alfa and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture. HEPATOLOGY 1995;21:1003-1010.
46. Higashi K, Kouba DJ, Song Y-J, Uitto J, Mauviel A. A proximal element within the human α2(I) collagen (COL1A2) promoter, distinct from the tumor necrosis factor-α response element, mediates transcriptional repression by interferon-γ. Matrix Biol 1998;16:447-456.
47. Ulloa L, Doody J, Massague J. Inhibition of transforming growth factor-β/Smad signalling by the interferon-γ/STAT pathway. Nature 1999;397:710-713.
48. Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, Heuchel R, Itoh S, et al. Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling. Nature 1997;389:631-635.
49. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994;264:1415-1421.
50. Decker T, Kovarik P, Meinke A. GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J Interferon Cytokine Res 1997;17:121-134.